Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Buscombe

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2018
Radioiodine and Its Relationship to Hematologic Malignancy: The Confounding Role of Supraphysiologic ThyroxineJohn Buscombe
Seminars in Nuclear Medicine|February 22, 2023
Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid CancerJohn Buscombe
Current Pharmaceutical Design|September 13, 2013
Radiolabeled probes targeting G-protein-coupled receptors for personalized medicineJohn Buscombe
World Journal of Nuclear Medicine|December 25, 2014
Excellence is the Enemy of GoodJohn Buscombe
World Journal of Nuclear Medicine|May 3, 2016
Selective Internal Radiation Therapy in Metastatic Carcinoma of the Colon: A Story of Nonintegrated Care?John Buscombe
Nuclear Medicine Communications|January 20, 2005
A new glossary for nuclear medicineJohn Buscombe
Journal of Nephrology|May 1, 2008
Sickle cell kidneyAndrew Davenport, John Buscombe
Expert Review of Anticancer Therapy|April 13, 2007
Is 18F FDG PET-CT cost effective in lung cancer?John Buscombe, E O'Rourke
Nuclear Medicine Communications|July 20, 2021
BNMS position statement on molecular radiotherapyGlenn Flux, John Buscombe,
Clinical Medicine (London, England)|August 31, 2012
Molecular radiotherapyJohn Buscombe, Shaunak Navalkissoor
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2018
Radioiodine and Its Relationship to Hematologic Malignancy: The Confounding Role of Supraphysiologic ThyroxineJohn Buscombe
Seminars in Nuclear Medicine|February 22, 2023
Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid CancerJohn Buscombe
Current Pharmaceutical Design|September 13, 2013
Radiolabeled probes targeting G-protein-coupled receptors for personalized medicineJohn Buscombe
World Journal of Nuclear Medicine|December 25, 2014
Excellence is the Enemy of GoodJohn Buscombe
World Journal of Nuclear Medicine|May 3, 2016
Selective Internal Radiation Therapy in Metastatic Carcinoma of the Colon: A Story of Nonintegrated Care?John Buscombe
Nuclear Medicine Communications|January 20, 2005
A new glossary for nuclear medicineJohn Buscombe
Journal of Nephrology|May 1, 2008
Sickle cell kidneyAndrew Davenport, John Buscombe
Expert Review of Anticancer Therapy|April 13, 2007
Is 18F FDG PET-CT cost effective in lung cancer?John Buscombe, E O'Rourke
Nuclear Medicine Communications|July 20, 2021
BNMS position statement on molecular radiotherapyGlenn Flux, John Buscombe,
Clinical Medicine (London, England)|August 31, 2012
Molecular radiotherapyJohn Buscombe, Shaunak Navalkissoor
Pageof 6